Updated on : 21-09-2025
| The Ministry of Food and Drug Safety (MFDS) is amending the “Regulations on Fees for Pharmaceutical Approval, etc.” as follows:A. Increase in application fees for biosimilar products approval and preliminary review (3 and 26 of Annex 1 in the Draft) The fees that have been applied to new biologics are separately classified as biosimilar products. The fee for manufacturing authorization (MA) is increased from 8.03 million won (approximately $5,782) to 310 million won (approximately $223,246), and the fee for preliminary safety/efficacy review from 3.01 million won (approximately $2,167) to 155 million won (approximately $111,623), to reflect actual circumstances.B. Fee reduction for biosimilar products from small and medium-sized enterprises (newly established Article 2 (4) (c) in the Draft)To reduce the fees for biosimilar products developed by small and medium-sized enterprises in Korea by 50%. C. Fee reduction of the second MA application for biosimilar products by the same applicant (3 and 26 of Annex 1 in the Draft)When the same applicant files the second application for a different dosage or injection dosage form (including vial, ampule, Pen) for the newly established biosimilar product fee, the current fees for new biologics are applied from the second application. |
| Title | Category | Created On |
|---|---|---|
| The 12th National SME Product Fair-2025 will be held from 07-14 December 2025 at the Bangladesh China Friendship Conference Center (BCFCC) in Agargaon, Dhaka. | Business | 2025-12-02 04:14:00 |
| Vietnam: Draft National technical regulation on baseline cybersecurity requirements for surveillance camera | TBT | 2025-11-30 06:21:28 |
| Japan: Partial Amendment of the Ordinance for Enforcement of the Radio Act, etc. | TBT | 2025-11-30 06:20:28 |
| Chinese Taipei: Proposal for Legal Inspection Requirements for Soother Holders | TBT | 2025-11-30 06:18:11 |
| Chinese Taipei: Amendments to the Legal Inspection Requirements for Power Conversion System | TBT | 2025-11-30 06:17:09 |